ACE (angiotensin converting enzyme) gene genotypes have been shown to be a risk factor for development of left ventricular hypertrophy and cardiomyopathy, upon the assumption that the DD genotype is linked to higher cellular ACE activity leading to myocardial fibrosis. To test an analogous hypothesis that the DD genotype favors myocardial fibrosis in the atrium and thus promotes atrial fibrillation without any structural heart diseases, we determined the distribution of the ACE gene genotypes in 77 patients with lone atrial fibrillation and investigated the effects of the ACE genotypes on the clinical characteristics of atrial fibrillation. The distribution of ACE genotypes was not significantly different between the patients and healthy volunteers. Also, the ACE gene genotypes did not affect the types of atrial fibrillation and the age at the onset of atrial fibrillation. Thus, these results refuted the hypothesis of possible relationships between ACE genotypes and lone atrial fibrillation through myocardial fibrosis, and indicated some unknown differences between the atrium and ventricle. (Jpn Heart J 1997; 38: 637-641) 
S YSTEMIC
and/or local activities of the renin-angiotensin system have been reported to play an important role in cardiac remodeling and fibrosis, since angiotensin II is one of the potent stimulants of both cardiac myocytes and fibroblasts.1,2) Some of the components of the renin-angiotensin system are also synthesized in the heart, and increased expression of these components is reported to result in progression of cardiac diseases. 3) In human hearts, because ACE (angiotensin converting enzyme) is the predominant pathway for angiotensin II formation,4) its higher local activity is believed to promote cardiac remodeling, including myocardial fibrosis.1-3) Cloning of human ACE cDNA and restriction fragment length polymorphism analysis identified an insertion/deletion (I/D) polymorphism of the ACE gene that consists of the presence (I) and absence (D) of a 287 by DNA fragment located in intron 16.5) Although the ACE gene polymorphism is probably only a neutral marker, DD genotype is known to be linked to higher levels of cellular ACE. In this context, the DD genotype has been shown to be a risk factor for the development of cardiomyopathy and cardiac hypertrophy, possibly through myocardial fibrosis in the ventricle. [6] [7] [8] In the present study, to test an analogous hypothesis that the DD genotype might favor myocardial fibrosis also in the atrium leading to atrial degenerative changes, the distribution of the ACE genotype polymorphism was determined in patients with lone atrial fibrillation (Af), in which fibrotic degenerative changes have been pathologically demonstrated.9) We compared the clinical characteristics of patients with Af among the ACE gene genotypes (Table) . In the present study, the patients with the D allele tended to be younger than those with the I allele, possibly because of early death of individuals with the DD genotype as previously suggested,12) but the difference was not statistically significant. The types of atrial fibrillation (chronic/paroxysmal) were not significantly different among the ACE gene genotypes. Age at the onset of Af tended to be younger in DD than in DI and II groups, but it was not significantly different among the genotype groups, although this tendency might have been resulted from differences in patient ages in the present study.
METHODS

DISCUSSION
After many investigators have reported specific relations between ACE gene polymorphism and cardiovascular diseases (left ventricular hypertrophy and idiopathic dilated cardiomyopathy),2-4) several mechanisms are under investigation. One of the speculated mechanisms is myocardial fibrosis: higher levels of angiotensin II associated with the DD genotype stimulate cardiac fibroblasts , resulting in an increase of extracellular matrix that would lead to progression of the diseases.5-7) This speculation leads to a hypothesis that the DD genotype favors Jpn Heart J September 1997 myocardial fibrosis. If this view holds true also with the atria, it is conceivable that fibrotic degeneration, which has been pathologically demonstrated in Af, is causative of Af or a progressive factor of Af in a considerable number of patients with DD genotype. This hypothesis predicts that the distribution of the D allele would be increased in patients with Af and without any structural heart diseases. However, this seemed not to be the case from the present result. The distribution of the ACE genotypes was similar between patients with lone Af and healthy volunteers. Also, because the types of Af (paroxysmal/chronic) did not differ among the ACE gene genotypes, the ACE gene genotypes seemed not to be related to progression of Af. Rather, our study questioned the speculated relationship between ACE genotypes and myocardial fibrosis in lone Af, while it might indicate some unknown differences between the atrium and ventricle. And, although the patients with Af were excluded from the study population in many previous reports that investigated the relationships between the ACE genotypes and cardiovascular diseases,5-7) the present result indicates no necessity for the exclusion.
However, we should recognize that Af does not result only from myocardial fibrosis in the atrium. Because Af in itself causes various changes in the atrium, including electrical remodeling,13) the pathological changes such as fibrosis or fatty changes could be the result of atrial fibrillation. In this respect, to determine the relationships between atrial myocardial fibrosis and ACE gene polymorphism, it would be preferab1le to examine the distribution of ACE gene polymorphism in patients with atrial fibrosis without Af. Atrial standstill may be a candidate disease, but this patient population is small and inappropriate for epidemiological study. Therefore, because the present result is limited to lone atrial fibrillation, the relationship between ACE gene polymorphism and atrial fibrosis requires further study.
